Abstract
Limb salvage surgery, which involves resection and reconstruction, is the commonly accepted method of treatment for musculoskeletal tumors today. While reconstruction can be performed by either biological or non-biological methods, tumor resection with safe margins is the minimum requirement for successful limb salvage. Local tumor control must be secured before any reconstruction effort, which will restore the anatomical integrity and function of the limb, since failure to do so will cancel out any seemingly successful reconstructive procedure. Various types of vascular and nonvascular structural autografts, recycled autografts, massive allografts, and distraction osteogenesis are the main tools of biological reconstruction, whereas megaprosthetic implants are the most important means of non-biological reconstruction. Although the indications for each of these methods may vary depending on patient demographics, tumor properties, socioeconomic and psycho-socio-cultural factors, healthcare policies, the capabilities of the medical institution, and finally the skill, knowledge, and experience of the surgeon, most cases can be labeled as more suitable for either biological or non-biological reconstruction in the light of prognostic factors, technical considerations, and short-to-long-term advantages and disadvantages. Some cases, on the other hand, may fall into a “gray-zone” category, where any decision about biological versus non-biological reconstruction and even limb salvage versus amputation is open to debate. Limb-sparing management of these cases requires a genuine understanding of patient expectations, detailed discussion of the risks and benefits of alternative treatment methods, utilization of extensive microsurgical support and other advanced surgical techniques, goal-oriented selection of implants, and a tailored neoadjuvant treatment, which might include unconventional use of chemotherapy and radiotherapy.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Bone tumor
- Musculoskeletal neoplasm
- Limb salvage surgery
- Limb function
- Biological reconstruction
- Joint-preserving surgery
- Tumor endoprosthesis
- Megaprosthesis
- Neoadjuvant treatment
- Chemotherapy
- Radiotherapy
- Microsurgery
1 Principles of Limb Salvage Surgery
The main principle of treatment for bone and soft tissue tumors is to remove the tumor in its entirety. There are two main methods for achieving this goal [1,2,3]:
-
1.
Amputation
-
2.
Limb Salvage Surgery (LSS)
Amputation, which is a form of ablative treatment, removes the tumor-afflicted extremity at a safe level. When compared to LSS, it can be performed in a much shorter duration, is a relatively easier procedure, and can facilitate faster recovery. Nevertheless, it is a radical procedure and a valuable part of the body is lost forever. For all illnesses, especially for cancer, motivation is an important part of the patient’s treatment process. This motivation is tremendously affected with the loss of a limb that comes with amputation. This, by itself, justifies the endeavor to salvage the limb.
Limb salvage surgery is the resection of the tumor with safe margins by including a cuff of healthy tissue while preserving the limb. The absolute requirement for attempting LSS is the probability of removing the tumor as safely as with an amputation. In addition to osseous or osteoarticular losses, resection may also involve sacrification of critical structures such as muscles, ligaments, skin, nerves, vessels, and/or neighboring organs. In a broad sense, the aim of subsequent reconstruction is to ensure integrity, viability, soft tissue coverage, and function of the limb. Despite the fact that reconstructive procedures are often the more intriguing and emphasized parts in LSS, reconstruction can never be considered apart from the resection. While an impressive and sophisticated reconstruction is likely to fail due to local recurrence in the setting of an inadequate resection, the patient’s survival is also at stake with compromised margins. On the other hand, a carefully planned and skillfully executed resection in a well-selected patient will sometimes mandate a certain type of reconstruction or give more than one reconstructive option to the surgeon. Nevertheless, the resection is dependent on tumor-related (specific pathology, location, size) and patient-related (demographics) or treatment-related (previous invasive diagnostic/inappropriate procedures, response to neoadjuvant treatment) factors. Therefore, LSS is a total concept including all things done (or not done) starting from the time of presentation to the completion of reconstructive efforts and even the completion of adjuvant treatment. LSS is the mainstay of treatment today for most musculoskeletal malignancies and the treatment protocols have been standardized for common pathologies like osteosarcoma and Ewing’s sarcoma in much of the developed world or the developing countries.
Van Nes rotationplasty is a very valuable intermediate surgical treatment method between amputation and LSS [2, 3]. When compared to amputation, it preserves significant function, avoids phantom limb pain, and results in less limb length discrepancy. However, cultural expectations, peculiar cosmesis, need for knowledge and experience of specific surgical technique, and the need for access to a skilled prosthetist limit its use.
In the light of this general perspective on amputation and LSS, the goals of treatment in musculoskeletal malignancies can be summarized and prioritized as:
-
1.
saving the patient’s life,
-
2.
saving the limb,
-
3.
preserving function of the limb,
-
4.
achieving good cosmesis of the limb,
-
5.
compatibility of the treatment method with psycho-socio-cultural status of the patient.
The treating team must adhere to these priorities and carefully assess issues such as the required knowledge, skill, experience, technical resources, and presence of a specialist team for each case. Respecting these criteria in the appropriate order and informing the patient and/or the family explicitly about the objectives that can be achieved, it is almost always possible to avoid an ablative surgery today. The local control rate is shown to be similar for amputation and LSS in the era of advanced imaging and multimodal adjuvant treatment. The decision to perform a limb-sparing surgery or what kind of reconstruction to undertake in extreme cases, however, is a very individualized process, which should take into account the total impact of the planned procedure on the patient and the medical team in terms of health-related quality of life, economical burden, psychosocial effects, allocation of medical resources, and oncological risks [2,3,4].
Reconstruction in limb salvage surgery can be performed in two ways:
-
1.
Biological reconstruction
-
Biological methods utilize materials, which are either living or have the capacity to revitalize and are obtained from either the patient (autograft) or from another person (allograft), to reconstruct the post-resection defect [5,6,7,8,9,10,11].
-
Distraction osteogenesis is also a very important, albeit less commonly used biological method in orthopedic oncology [12].
-
The definition of biological reconstruction may be extended to include hybrid methods (e.g., allograft/recycled autograft and prosthesis composites) and biological aspects of non-biological methods (e.g., bone lengthening in the setting of tumor prosthesis or bioexpandable prostheses) [5, 13].
-
-
2.
Implant (non-biological) reconstruction
-
Tumor prostheses or megaprostheses are the main instruments of non-biological defect reconstruction [14, 15].
-
Bone cement is also a very versatile non-biological material, which can be used with tumor prostheses or osteosynthesis implants for defect reconstruction.
-
Non-biological methods may harbor biological components (e.g., graft/prosthesis composites or bioexpandable parts) as also mentioned for biological methods [5, 13].
-
2 When and Why Biological Reconstruction?
The main advantage of biological reconstruction is that when the healing process is complete, the reconstruction material becomes totally incorporated into the patient’s body [5,6,7,8,9,10,11]. The biologically reconstructed segment, which either maintains its vitality and thus unites with the recipient site or regains its vitality by creeping substitution after uniting with the recipient site, eventually becomes the patient’s own. The living nature of the healed segment gives it responsive capability so that it can remodel, heal if it is fractured or hypertrophy under weight-bearing conditions (Fig. 1.1). Therefore, biological reconstruction offers a potentially life-long limb salvage solution, which even facilitates safe participation in recreational activities in survivors of musculoskeletal malignancies.
Biological reconstruction reduces soft tissue problems through three different mechanisms. Biological materials occupy less space (Fig. 1.2), allows adherence of soft tissues onto their surfaces, and also may bring their own soft tissue cover as in an osteo-myofasciocutaneous flap. Hence, wound problems and secondary deep infections are less commonly encountered. Furthermore, early postoperative complications such as infected hematoma can be effectively treated. If the healing of biological reconstruction fails partially, as would be the case in the setting of mechanical insufficiency while the graft’s vitality is preserved, complications like graft fracture or nonunion might occur and yet can be treated by revision of osteosynthesis as in a normal fracture (Fig. 1.3). Limb length discrepancy can be managed in the same way as in a non-oncological setting (Fig. 1.4). If, however, biological potential has been lost or cannot be regained in a reasonable time, the reconstructed segment might end up as dead bone and fail totally due to deep infection and/or resorption. Biological reconstruction has the advantage of possible conversion to implant reconstruction even in this worst-case scenario (Fig. 1.5).
While biological methods yield durable reconstructions with relatively less morbid and biologically manageable complications, the major disadvantage is the substantially long healing time, which particularly causes problem regarding lower extremity reconstructions due to prolonged period of restricted weight-bearing (Fig. 1.6). These limb salvage considerations are most compatible with a patient who has a high likelihood of survival and thus can afford to wait for the lengthy healing period. This, in turn, depends on the presence of good prognostic factors such as being non-metastatic at presentation, showing a good neoadjuvant treatment response, not having a large tumor and not having sustained a pathological fracture.
On the other hand, certain disadvantages associated with implant reconstruction, such as loss of joint surfaces, loss of physeal plates on both sides of the joint, and loss of bone stock, which could actually be spared, make biological reconstruction with intercalary resection the treatment of choice for some cases or a necessity in others. The feasibility of a safe intercalary resection is closely related with radiological findings. An interim radiological evaluation may be reasonable in cases, for which biological reconstruction is planned. For example, a magnetic resonance imaging (MRI) examination performed after the second cycle of a “3-cycle neoadjuvant chemotherapy” may demonstrate whether if radiological response is good and therefore intercalary resection is safe or if there is tumor progression and an endoprosthetic reconstruction will be safer. Thus, the reconstruction strategy may be worked out before final preoperative MRI. Which MRI parameters should be used to determine surgical margins are open to debate. While the safest margins can be accepted as those determined according to pre-chemotherapy short tau inversion recovery (STIR) or turbo inversion recovery magnitude (TIRM) sequences on MRI, the margins most encouraging for intercalary resection, are those determined according to post-chemotherapy contrast-enhanced sequences in a good-responder. As a general rule, the surgical margins are determined according to radiology at presentation for osteosarcoma and according to follow-up imaging after neoadjuvant treatment for Ewing’s sarcoma since chemosensitivity and radiosensitivity are thought to play a bigger role in local tumor control in the latter pathology.
Although more rarely performed, biological reconstruction may also play an important role after intraarticular resection in small children (Fig. 1.7) and particularly in the upper extremity. Long-term complications of implant reconstruction, such as periprosthetic infection, inevitable need for revision, and continuing loss of bone stock, also bring forth biological reconstruction as the method of choice, in younger patients, particularly in the skeletally immature.
Biological reconstruction might be considered economically advantageous when compared to implant reconstruction in general. While this advantage may vary according to specific method of biological reconstruction used, harvesting a non-vascular structural bone graft has virtually no cost and recycling techniques, such as liquid-nitrogen cryotreatment, autoclaving, and pasteurization, also have minimal economic impact and demand minimal resource and equipment. While microsurgical reconstruction with a vascular bone flap is a time, resource, and effort demanding procedure, it can still be considered as a relatively low-cost treatment if utilized in a specialized center setting where the procedure is being performed routinely by a dedicated microsurgery team. The availability of a national bone bank might also favor massive allograft use as a more economical option compared to implant reconstruction. Finally, the long-term solution provided by biological reconstruction also eliminates the costs of future implant revisions.
In the light of these treatment concerns, biological reconstruction may be best indicated in a younger patient with good prognostic factors and a tumor suitable for safe intercalary resection (Figs. 1.8 and 1.9). Wound problems are better prevented or managed with biological reconstruction. While economic factors should not be cited as a criterion for determining the best treatment strategy, they often emerge as a reality of medical procedures and biological methods offer serious advantages to implant reconstruction.
3 When and Why Implant (Non-biological) Reconstruction?
Advanced design features of modern-day implants facilitate near-normal biomechanics especially around the knee joint, which frequently undergoes non-biological reconstruction in the oncological setting [14, 15]. Furthermore, the modularity of most megaprosthetic systems used today allows the surgeon to precisely adjust the extremity length and rotation and to modify the reconstruction plan intraoperatively [14, 15]. These aspects provide great comfort for both the patient and the surgeon. Taking into account the good function and the relative ease of application, implant reconstruction should be considered as the treatment of choice when the joint surface cannot be salvaged due to tumor invasion or proximity and an intraarticular (or extraarticular) resection is warranted. While epiphyseal tumor involvement in MRI is not an absolute indication for intraarticular resection, plain infiltration of the joint cartilage, extension into the joint space or extension over the ligaments, and joint capsule mandate an intraarticular (or extraarticular) resection (Figs. 1.10, 1.11, 1.12 and 1.13).
Implant reconstruction offers the main advantage of almost immediate or at least faster recovery of functions depending on anchorage properties, such as the use of cemented or cement-less stems, and any associated soft tissue reconstruction. Similarly, early weight-bearing can often be allowed in the lower extremity in stark contrast to biological reconstruction. Therefore, the healing time is substantially shorter for implant reconstruction than that of biological reconstruction. Patients with bad prognostic factors such as being metastatic at presentation, showing a bad neoadjuvant treatment response, having a large tumor, and having sustained a pathological fracture should be very carefully assessed for biological reconstruction and must strongly be considered for implant reconstruction since the prognosis is often incompatible with the prolonged healing expected in biological methods (Fig. 1.14). Although pediatric patients tolerate and function very well with implant reconstruction especially around the knee, biological reconstruction is reserved as the primary option for them due to above-mentioned reasons. Nevertheless, implant reconstruction should be favored particularly in adults with lower extremity tumors due to their relatively diminished bone healing capacity, increased body weight, and time constraints related to going back to work and other daily activities. Consequently, an adult patient with bad prognostic factors and a lower extremity tumor where the joint is non-salvageable is the ideal candidate for implant reconstruction.
An important yet debatable indication for implant reconstruction might be not having the surgical skill, experience, infrastructure, and organization to perform a biological reconstruction where an intercalary resection might be considered. The orthopedic oncologist might not be familiar with the biological method(s); a microsurgeon and/or necessary operation room setting for microsurgery, equipment, and facilities required for bone recycling or bone bank for allograft use might not be available. Furthermore, tumor destruction may render the bone useless as a recycled autograft, the patient might not accept any donor-site morbidity ruling out any graft/flap harvest, and the patient may not allow the use of cadaveric bone grafts due to sociocultural and/or religious reasons. Patients might also reject biological reconstruction due to concerns about oncological safety of bone recycling methods or viral disease transmission risk associated with fresh frozen massive allografts. In such cases, the most biological approach for an implant reconstruction must be sought. If, for example, intercalary resection can be performed, the joint might be salvaged and an intercalary diaphyseal endoprosthesis might be implanted.
4 The Gray Zone
Some cases of musculoskeletal tumors fall into a gray zone with regard to whether a limb salvage surgery can be performed or not, before any discussion of whether biological or implant reconstruction is better indicated. A huge exulcerated tumor or one with imminent skin breakdown, neurovascular involvement, and anticipation of significant soft tissue defect are common features. These cases, especially if they are skeletally immature, might actually be good candidates for Van Nes rotationplasty. However, psycho-socio-cultural incompatibility may exclude rotationplasty in some cases.
Yet for other cases in the gray zone, the indication for limb salvage surgery might be a definite one but the decision to perform a biological or implant reconstruction is difficult with regard to oncological safety and possible critical gains with the biological method. In certain cases, neither method is clearly the better choice. In those cases, the patient’s and the treating team’s preferences are decisive. In rarer cases, when a significant advantage or dramatic difference in treatment outcome is anticipated, riskier and unconventional solutions might be sought instead of conventionally accepted methods. There are certain prerequisites, however, to implement such unconventional methods. Any intended reconstructive gain must not breach the principles of safe resection and compromise local control under any circumstance. Tailoring the chemotherapeutic regimen according to interim clinical and radiological evaluations, preoperative use of radiotherapy or concomitant chemoradiotherapy (even in not very sensitive tumors like osteosarcoma) (Figs. 1.15 and 1.16), special resection techniques (Figs. 1.17, 1.18, and 1.19), advanced neurovascular reconstruction, and extensive use of both local and free flaps (Fig. 1.20) can all be used to “safely modify” the surgical margins rather than violating them [16,17,18,19,20,21]. For these reasons, such unconventional procedures should only be undertaken by a competent and experienced multi-disciplinary team in a specialized orthopedic oncology center, which can provide the necessary technical resources, after an extensive discussion with the patient regarding all options, risks, and possible complications.
Provided that all aspects of limb salvage surgery are under control, such “innovative” and “extraordinary” procedures offer prospective benefits in terms of function, complications, and oncological outcome. Even if the long-term outcome is not excellent for a specific limb salvage procedure, preserved joint or bone stock might pave the way for conversion to another limb salvage method (Fig. 1.21) or to a more functional amputation at a later age, for example, for a skeletally immature child.
5 Conclusion
Both biological and non-biological methods have their own advantages and disadvantages. At the same time, each method has its unique indications as well as overlapping ones. While the choice of treatment is clear-cut for some cases, the indications might fall into a “gray zone” category in others where multiple parameters must be considered simultaneously in the light of surgeon’s and/or institution’s capabilities and experience. To conclude which reconstruction should be preferred when and why, one must first remind the unchanging limb salvage philosophy with the following analogy:
Tumor resection with safe margins denotes "1"; each achieved limb salvage goal puts a "0" beside "1", adding value to the treatment. Thus, preserving the limb yields "10", a functional limb "100", good cosmetic appearance "1000" and so on. If the margins are compromised, however, the surgeon and the patient are left with a "0" to begin with and all reconstruction efforts whether biological or implant are cancelled out.
References
Malawer MM, Sugarbaker PH. Musculoskeletal cancer surgery treatment of sarcomas and allied diseases. The Netherlands: Kluwer Academic Publishers; 2001. p. 13–7.
Wooldridge AN, Anderson CJ, Scarborough MT. Decision making for skeletal reconstruction options in the growing child. Techn Orthop. 2018;33(3):183–90. https://doi.org/10.1097/BTO.0000000000000313.
Morris CD, Wustrack RL, Levin AS. Limb-salvage options in growing children with malignant bone tumors of the lower extremity. JBJS Rev. 2017;5:e7. https://doi.org/10.2106/JBJS.RVW.16.00026.
Futani H. Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur. J Bone Joint Surg. 2006;88:595–603. https://doi.org/10.2106/JBJS.C.01686.
San-Julian M, Vazquez-Garcia B. Biological reconstruction in bone sarcomas: lessons from three decades of experience. Orthop Surg. 2016;8:111–21. https://doi.org/10.1016/j.ocl.2006.10.008.
Yamamoto N, Hayashi K, Tsuchiya H. Progress in biological reconstruction and enhanced bone revitalization for bone defects. J Orthop Sci. 2019;24:387–92. https://doi.org/10.1016/j.jos.2019.01.015.
Innocenti M, Delcroix L, Romano GF, Capanna R. Vascularized epiphyseal transplant. Orthop Clin North Am. 2007;38:95–101; vii. https://doi.org/10.1016/j.ocl.2006.10.003.
Ozger H, Sungur M, Alpan B, Kochai A, Toker B, Eralp L. 4.P.14 The combined use of recycled bone and vascularised fibula in limb-salvage surgery for musculoskeletal malignancies—the bone in the bun technique (Hot Dog technique). Orthop Proc. 2018;92-B(SUPP_III):454–5.
Capanna R, Campanacci DA, Belot N, Beltrami G, Manfrini M, Innocenti M, Ceruso M. A new reconstructive technique for intercalary defects of long bones: the association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques. Orthop Clin N Am. 2007;38(1):51–60.
Tsuchiya H, Wan SL, Sakayama K, Yamamoto N, Nishida H, Tomita K. Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg Br. 2005;87(2):218–25.
Ozger H, Akgul T, Yildiz F, Topalan M. Biological reconstruction of the femur using double free vascularized fibular autografts in a vertical array because of a large defect following wide resection of an osteosarcoma: a case report with 7 years of follow-up. J Pediatr Orthop B. 2013;22(1):52–8.
Tsuchiya H, Shirai T, Morsy AF, Sakayama K, Wada T, Kusuzaki K, Sugita T, Tomita K. Safety of external fixation during postoperative chemotherapy. J Bone Joint Surg Br. 2008;90:924–8. https://doi.org/10.1302/0301-620X.90B7.20674.
Baumgart R, Hinterwimmer S, Krammer M, Muensterer O, Mutschler W. The bioexpandable prosthesis: a new perspective after resection of malignant bone tumors in children. J Pediatr Hematol Oncol. 2005;27:452–5. https://doi.org/10.1097/01.mph.0000178268.07830.d5.
Ozger H, Alpan B. Innovation in prosthetic system: PENTA modular extremity reconstruction system. TOTBID J. 2021;20:66–72. https://doi.org/10.14292/totbid.dergisi.2021.11.
Pala E, Trovarelli G, Angelini A, Maraldi M, Berizzi A, Ruggieri P. Megaprosthesis of the knee in tumor and revision surgery. Acta Biomed. 2017;88(2S):129–38. https://doi.org/10.23750/abm.v88i2.
DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys. 2005;61:492–8. https://doi.org/10.1016/j.ijrobp.2004.05.051.
Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, Toscano A, Alì N, Ruggieri P, Alberghini M, Picci P, Bacci G, Mercuri M. Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther. 2011;11:217–27. https://doi.org/10.1586/era.10.172.
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S. The role of radiotherapy in oseosarcoma. Cancer Treat Res. 2009;152:147–64. https://doi.org/10.1007/978-1-4419-0284-9_7.
Andreou D, Bielack SS, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A, Ewerbeck V, Heise U, Reichardt P, Tunn P-U. The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Ann Oncol. 2011;22:1228–35. https://doi.org/10.1093/annonc/mdq589.
Bertrand TE, Cruz A, Binitie O, Cheong D, Letson GD. Do surgical margins affect local recurrence and survival in extremity, nonmetastatic, high-grade osteosarcoma? Clin Orthop Relat Res. 2016;474(3):677–83. https://doi.org/10.1007/s11999-015-4359-x.
Li X, Moretti VM, Ashana AO, Lackman RD. Impact of close surgical margin on local recurrence and survival in osteosarcoma. Int Orthop. 2011;36:131–7. https://doi.org/10.1159/000306140.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Özger, H., Alpan, B. (2022). When and Why Biological/Implant Reconstruction?. In: Özger, H., Sim, F.H., Puri, A., Eralp, L. (eds) Orthopedic Surgical Oncology For Bone Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-73327-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-73327-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-73326-1
Online ISBN: 978-3-030-73327-8
eBook Packages: MedicineMedicine (R0)